BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pischiutta F, Caruso E, Lugo A, Cavaleiro H, Stocchetti N, Citerio G, Salgado A, Gallus S, Zanier ER. Systematic review and meta-analysis of preclinical studies testing mesenchymal stromal cells for traumatic brain injury. NPJ Regen Med 2021;6:71. [PMID: 34716332 DOI: 10.1038/s41536-021-00182-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Pischiutta F, Caruso E, Cavaleiro H, Salgado AJ, Loane DJ, Zanier ER. Mesenchymal stromal cell secretome for traumatic brain injury: Focus on immunomodulatory action. Exp Neurol 2022;357:114199. [PMID: 35952763 DOI: 10.1016/j.expneurol.2022.114199] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Skibber MA, Olson SD, Prabhakara KS, Gill BS, Cox CS. Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction. Front Immunol 2022;13:874698. [DOI: 10.3389/fimmu.2022.874698] [Reference Citation Analysis]
3 Meyfroidt G, Bouzat P, Casaer MP, Chesnut R, Hamada SR, Helbok R, Hutchinson P, Maas AIR, Manley G, Menon DK, Newcombe VFJ, Oddo M, Robba C, Shutter L, Smith M, Steyerberg EW, Stocchetti N, Taccone FS, Wilson L, Zanier ER, Citerio G. Management of moderate to severe traumatic brain injury: an update for the intensivist. Intensive Care Med 2022. [PMID: 35595999 DOI: 10.1007/s00134-022-06702-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]